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The yeast two-hybrid system was used to identify
binding partners of NuMA, a component of the nuclear
matrix in interphase cells. By using the C-terminal half
of NuMA as bait, a human cDNA sequence coding for a
223-amino acid protein with a non-helical N-terminal
domain and a C-terminal a-helical portion was identi-
fied and fully sequenced. It was identical to GAS41, a
sequence amplified in human gliomas. The sequence of
the homologous Drosophila protein was established,
and the alignment for GAS41 from nine different species
showed that GAS41 is a general eukaryotic protein
found in species as diverse as Arabidopsis, Drosophila,
Caenorhabditis elegans, yeast, and man. Northern blot
analysis showed a single transcript in eight human tis-
sues. A polyclonal antibody to GAS41 showed a dotted
staining pattern in interphase nuclei and a uniform dis-
tribution in mitotic cells. A GFP-GAS41 fusion protein
displayed equivalent patterns. In vitro GAS41 bound to
the C-terminal part of the rod region of NuMA, as shown
by dot overlay and by surface plasmon resonance meas-
urements. The Kd of the complex was 2 3 10
27 M. GAS41
is related to the AF-9 and ENL proteins, which are pu-
tative transcription factors found as fusion proteins in
some acute leukemias. The NuMA/GAS41 interaction
may provide a link between nuclear structure and gene
expression.
The knowledge of proteins that form the nuclear skeletal
structure in interphase is still incomplete. NuMA, the nuclear
mitotic apparatus protein, is a protein that shows a striking
change in localization during the cell cycle moving from the
nuclear matrix in interphase to the spindle poles in mitotic
cells (1). This change in location is accompanied by specific
changes in phosphorylation of the NuMA molecule (2, 3) and
presumably also by changes in the binding partners with which
NuMA interacts. In interphase NuMA is a component of the
nuclear matrix since it remains insoluble after DNase and high
salt treatments of the nucleus. It is also resistant to extraction
by non-ionic detergents, but it can be solubilized by high con-
centrations of urea (1, 4, 5). NuMA can bind specifically to DNA
matrix regions (6). It also binds to the nonerythroid isoform of
protein 4.1R located within the nucleus (7).
Transient overexpression of NuMA in HeLa cells results in
regular nuclear networks that fill the nucleus, are stable to
detergent extraction, and can be visualized by electron micros-
copy. Immunoelectron microscopy shows that these nuclear
lattices are built from NuMA (8). In addition, we have shown
that recombinant NuMA expressed in Escherichia coli can self-
assemble in vitro under physiological salt conditions into a
novel higher order structure, the multiarm oligomer. Computer
modeling suggests that these oligomers could be the structural
unit of the lattices seen in electron microscopy in the nuclei of
cells transfected with NuMA (9). These lattices could possibly
provide a framework where nuclear processes such as tran-
scription take place.
The importance of NuMA in interphase as well as the fact
that it plays an essential role in mitosis (4, 10–12) suggest that
it would be of interest to characterize binding partners. We
therefore used the yeast two-hybrid system (13) to screen a
HeLa library for proteins that interact with NuMA. Our screen
has revealed surprisingly that the protein product of a gene
previously shown to be amplified in gliomas (GAS41) is a bind-
ing partner for NuMA. GAS41 is amplified in 23% of glioblas-
tomas and in 80% of grade I astrocytomas. GAS41 was the first
gene shown to be amplified in low grade glioma, and its defi-
nition showed that gene amplification is not limited to late
events in tumor progression (14). Here we report that GAS41 is
a highly conserved protein since homologs to the human form
were found in Arabidopsis, Drosophila, Caenorhabditis el-
egans, and yeast. We further show that GAS41 is a nuclear
protein giving a dotted pattern in interphase cells and is pres-
ent in a variety of human tissues. The specific interaction of
GAS41 with NuMA was confirmed in vitro by immunoprecipi-
tation experiments and surface plasmon resonance binding
assays.
EXPERIMENTAL PROCEDURES
RNA Preparation—mRNA was prepared using the messenger RNA
isolation kit from Stratagene (La Jolla, CA). HeLa cells were homoge-
nized in guanidinium isothiocyanate and b-mercaptoethanol. 39-Poly-
adenylated mRNA was isolated using oligo(dT)-cellulose. Drosophila
melanogaster embryo poly(A)1 RNA was obtained from CLONTECH.
Construction of the pAD-GAL4 cDNA Library and Two-hybrid
Screening—Starting from 5 mg of poly(A)1 RNA, a cDNA library of
HeLa cells was constructed in the phagemid pAD-GAL4 (GAL4 activa-
tion domain vector) using the HybriZAP two-hybrid cDNA Gigapack
cloning kit (Stratagene) followed by mass excision. cDNA synthesis was
oligo(dT)-primed. This library was used to identify novel components
that interact with “bait” NuMA cDNA constructs. Different NuMA
cDNA fragments obtained by PCR1 amplification and EcoRI and SalI
treatment were ligated into the corresponding sites of pBD-GAL4
(GAL4 binding domain vector, Stratagene). PCR amplification was done
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using Vent polymerase (New England Biolabs, Schwalbach, Germany),
which has 39 to 59 proofreading exonuclease activity. NuMA clones l1
and l2 (5), or full-length cDNA, were used as template. Primer pairs for
the different two-hybrid bait constructs (Fig. 1) and the amino acid
residues in which they result were as follows: N (33, 54; 1–1068), C (53,
38; 1048–2115), H (33, 55; 1–215), T (35, 38; 1701–2115), Ncoil (27, 54;
216–1068), and Ccoil (53, 39; 1048–1700) (see Table I). To screen for
interacting proteins the Saccharomyces cerevisiae strain YRG-2 (Strat-
agene) was sequentially transformed with the bait (NuMA-cDNA) and
the HeLa library containing phagemids using the LiAc method. Clones
were examined for transcriptional activation of reporter genes his3 and
b-galactosidase (filter lift) indicating interaction between bait/binding
domain and library/activation domain constructs. Only clones meeting
all standard two-hybrid specificity tests were considered as positive.
These tests included absence of an interaction between the target
construct and p53 and pLaminC-negative control constructs and the
inability of colonies containing the target construct alone, or target and
bait vector without insert, to pass His2 and b-galactosidase assays.
Positive clones were partially sequenced.
59-Rapid Amplification of cDNA Ends (59-RACE)—59-RACE experi-
ments were performed using the Marathon cDNA amplification kit
(CLONTECH) and HeLa messenger RNA.
Northern Blots—A PCR-amplified 1055-bp DNA fragment (bp 210–
1264) of the GAS41 cDNA coding sequence was radiolabeled with
[a-32P]dCTP using a random hexamer labeling kit (Quick Prime, Am-
ersham Pharmacia Biotech), and the probe was purified with a Qia-
quick nucleotide removal kit (Qiagen, Hilden, Germany). The probe
supplemented with 100 mg of salmon sperm DNA was hybridized with
a multiple tissue Northern blot (CLONTECH, Palo Alto, CA) containing
2 mg of purified poly(A)1 RNA from various human tissues in Ex-
pressHyb hybridization solution (CLONTECH) for 1 h at 68 °C. The blot
was then extensively washed following the manufacturer’s recommen-
dations and subjected to autoradiography at 270 °C. A human b-actin
cDNA probe was used as control.
GFP Plasmid Construction—First strand cDNA synthesis was initi-
ated using the oligo(dT) anchor primer of the 59–39 RACE kit from
Roche Molecular Biochemicals. After converting mRNA into cDNA
GAS41-cDNA was amplified using the gene-specific primer AGATC-
TATATGTTCAAGAGAATGGCCG (BglII site underlined) and the PCR
anchor primer GACCACGCGTATCGATGTCGAC, which includes a
SalI site. The amplified product was cloned into the BglII and SalI site
of the pEGFP-C2 vector (CLONTECH). Immunocytochemistry and
transient transfection used standard techniques (4, 15). Cells were
examined 24 h post-transfection.
Antibodies—Monoclonal NuMA SPN3 antibody (4, 5) was used as
undiluted hybridoma supernatant. The rabbit GAS41 antibody was
raised by injecting a peptide covering residues 206–222 of GAS41
coupled to ovalbumin. The antibody was affinity-purified using the
peptide coupled to EAH-Sepharose 4B with the linker m-maleimidoben-
zoyl-N-hydroxy-sulfosuccinimide ester by the N-terminal cysteine res-
idue. Anti-GFP rabbit antiserum was from Molecular Probes, (Eugene,
OR).
Expression and Purification of l1a and l2b Constructs—SOB me-
dium (20 g of tryptone, 5 g of yeast extract, 0.5 g of NaCl, 0.186 g of KCl,
and 20 mM MgCl2 per liter H2O) containing ampicillin (100 mg/ml) and
chloramphenicol (34 mg/ml) was inoculated with a single recombinant
E. coli BL21(DE3)pLysS colony that contained the appropriate plasmid
and grown overnight at 37 °C with shaking. This culture was used to
inoculate 400 ml of SOB medium with antibiotics. The culture was
grown at 37 °C with shaking until it reached an absorbance at 600 nm
of 0.5. Expression was initiated by adding isopropyl-1-thio-b-D-galacto-
pyranoside to a concentration of 1 mM. After about 4 h, cells were
harvested by centrifugation. The purification of the soluble recombi-
nant constructs l1a and l2b was as described in Ref. 9.
Expression and Purification of GST and GST-GAS41—GAS41 was
expressed as a C-terminal fusion with glutathione S-transferase (GST).
GAS41 was amplified by PCR. The following primers were used: 59-
dGGATCCATGGCCGAATTTGGGCCTGACTCC (sense) and 59-dCTC-
GAGTTATATGTCTTTTGCTTGGTCATC (antisense) (restriction sites
are underlined). The product was cloned into the BamHI and XhoI sites
of pGEX-KT expression vector. A single E. coli colony BL21 DE3(pLysS)
transformed with the construct was used to inoculate 23 YTG (23 YT
1 2% glucose) with the antibiotics chloramphenicol (34 mg/ml) and
ampicillin (100 mg/ml). Cultures were grown at 28 °C to an absorbance
at 600 nm of 0.6. Then cultures were transferred to 14 °C, and expres-
sion was induced with 0.1 mM isopropyl-1-thio-b-D-galactopyranoside.
After expression for ;20 h cells were harvested and resuspended in
PBS with protease inhibitors (Complete Mini, EDTA-free, Roche Mo-
lecular Biochemicals). After sonication Triton X-100 was added to 1%.
The extract was incubated for 30 min at 4 °C with rotation and then
centrifuged for 15 min at 12,000 3 g at 4 °C. The supernatant was
filtered (0.45 mm) and mixed with equilibrated glutathione-Sepharose
4B (Amersham Pharmacia Biotech). After 1 h incubation at room tem-
perature the matrix was extensively washed with PBS, and the GST
fusion protein was eluted with 10 mM glutathione in 50 mM Tris-HCl,
pH 8. Fractions containing the fusion protein were pooled and dialyzed
against the buffer of interest. GST protein was expressed in pGEX-KT
and purified under standard conditions following the protocol supplied
by Amersham Pharmacia Biotech.
Gel Electrophoresis and Western Blot Analysis Were by Standard
Procedures—SDS polyacrylamide gel electrophoresis was on 12.5% ac-
rylamide gels. Proteins were transferred to nitrocellulose using the
semi-dry transfer procedure (5).
Ligand Interaction Studies—To determine dissociation constants
(Kd) surface plasmon resonance studies were performed using the BIA-
core 2000 apparatus (BIAcore, Uppsala, Sweden). Purified NuMA con-
structs l1a and l2b were immobilized on a CM5 sensor chip via their
primary amino groups following the manufacturer’s instructions. Both
proteins were coupled at a density of 9000 resonance units. For all
further experiments, PBS (137 mM NaCl, 4.3 mM Na2HPO4, 1.4 mM
KH2PO4, 2.7 mM KCl, pH 7.3) was used as running buffer at a flow rate
of 20 ml/min. 0.5% SDS, 10 mM NaOH was used to regenerate the sensor
surface after each experimental cycle (16). Purified GST-GAS41 fusion
protein was used at concentrations ranging from 50 to 1000 nM, and
GST as a control to monitor nonspecific binding. Protein concentrations
were determined by the Bradford assay (17). The rate constants were
determined with the BIAcore evaluation software 3.0, assuming first
order kinetics (1:1 interaction).
RESULTS
Identification of a Binding Partner for NuMA in the Yeast
Two-hybrid Assay—The two-hybrid system was used to screen
for proteins that interact with NuMA. We used the fusion
protein GAL4-BD/NuMA-C (amino acid residues 1048–2115 of
NuMA) as a bait in the pBDGAL4 vector (Fig. 1A) and a human
HeLa cDNA library in lHybriZAP fused to the GAL4 activation
domain in pADGAL4. ;5 3 106 cotransformants were
screened. Around 30 colonies grew on agar lacking histidine
and of those 5 colonies expressed lacZ. Here we focus on the
interaction of one clone (clone X) and NuMA-C in the two-
hybrid assay. This was specific (Fig. 1B), since neither the
GAL4-BD NuMA-C hybrid interacted with the unfused GAL4-
TABLE I
Sequence of primers used for PCR amplification of pBD-GAL4 constructs
The restriction enzyme site within the primer sequence is underlined. The stop codon is shown in bold. Base pair positions refer to the sequence
of Yang et al. (31).
PCR







27 GCATGAATTCATGAGACGGCTGAAGAAGCAGCTTGCTG EcoRI 802 829
33 GCATGAATTCATGACACTCCACGCCACCCGGGGGGCTG EcoRI 157 184
35 GCATGAATTCCAGGTGGCAACTGATGCTTTAAAGAGCCG EcoRI 5257 5285
38 GGCATGTCGACTTAGTGCTTTGCCTTGCCCTTGGCTCGAG SalI 6501 6476
39 GGCATGTCGACTTAGAATTTGCCCAGGTCTCGAAGCTGCTGG SalI 5256 5229
53 GCATGAATTCCTGCAAGAGGCACTGGCTCATGCCCTGAC EcoRI 3298 3326
54 GGCATGTCGACTTACTTGGCCAACTCCTGGTCCTTGCCTTCC SalI 3360 3333
55 GGCATGTCGACTTACTGGAACTGTGGGGTCTGCAGGATATCAC SalI 801 773
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AD, nor did the GAL4-AD-X hybrid interact with the unfused
GAL4-BD (data not shown). Fusing the original bait (NuMA-C)
into the pAD vector and the target protein into the pBD vector
also gave a positive result (Fig. 1B). The same clone was found
in a second independent screen. This led to the isolation of a
cDNA clone with a length of 652 base pairs. This clone X
showed an open reading frame of 50 amino acids and a long
39-translated region that included a polyadenylation signal and
the poly(A) tail. The interaction of clone X with the other
NuMA constructs shown in Fig. 1A was also tested. Clone X
interacted strongly with the C-terminal part of the coiled-coil
rod domain (amino acid residues 1048–1700). Thus it inter-
acted with the NuMA C and the NuMA Ccoil constructs but did
not interact with the N, H, T, or Ncoil constructs (Fig. 1B). The
data from the two-hybrid assay show that the C-terminal 50
amino acids predicted by the clone X sequence bind to residues
1048–1700 of NuMA.
Since the HeLa library was oligo(dT)-primed, we used the
59-RACE technique to obtain the sequence 59 to the new cDNA.
The full-length cDNA was amplified, cloned, and sequenced.
The nucleotide and corresponding amino acid sequences are
shown in Fig. 2A. DNA sequencing revealed a nucleotide se-
FIG. 1. A, top, secondary structure of NuMA indicating the long
coiled-coil region flanked by non-helical head and tail domains. Middle,
constructs used for the two hybrid system (N, C, H, T, Ncoil, and Ccoil).
Bottom, constructs used for the in vitro binding assay (l1a and l2b).
The amino acid sequence numbers for NuMA are shown in the 2nd line,
and the exact limits of each of the constructs are given in the text. B,
specific interaction between NuMA and GAS41 observed by the yeast
two-hybrid system. The bait protein (the NuMA construct) was fused to
the GAL4 DNA-binding domain (pBD vector). The interacting protein
that was fused to the GAL4 activation domain (pAD vector) activates
the transcription of the HIS3 and lacZ genes when the probe and
interactor associate physically. Constructs in the pAD vector are always
in the top line, and constructs in the pBD vector are always in the
bottom line. Note that clone X interacted strongly with constructs
containing the C-terminal part of the coiled-coil rod domain but did not
react with the H, T, N, or Ncoil constructs. Cloning X into the pBD
vector and NuMA C into the pAD vector also revealed strong interac-
tion. The unlabeled parts of this figure are not relevant to this study.
FIG. 2. A, the nucleotide and corresponding amino acid sequence of
human GAS41. The translational stop codon is marked by an asterisk.
The underlined protein sequence indicates the residues where the
cDNA was fused to the GAL4 activation domain (the original clone from
the two-hybrid screen). The polyadenylation signal in the 39-translated
region is underlined. These sequence data have been submitted to the
EMBL data base under accession number AJ245746. B, secondary
structure of GAS41. Predictions were made using the Chou-Fasman
algorithm (28) with the overall probability procedure introduced by
Nishikawa (29) (top) or the Garnier-Osguthorpe-Robson algorithm (20)
of the Wisconsin Package GCG (bottom). C, hydrophobicity blot accord-
ing to Kyte and Doolittle (30) with a window size of 10 residues.
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quence of 1393 bases that contains a single open reading frame.
There are two ATG codons at nucleotides 212 and 224. We
consider that initiation is more likely to occur at the second
ATG codon since experiments using site-directed mutagenesis
have confirmed the importance of G14 for initiation of transla-
tion in higher eukaryotes (18). Moreover the N-terminal align-
ment of the human sequence with that of other species (Fig. 3)
is in favor of the second ATG. An in-frame stop codon upstream
is found at position 80. The open reading frame is followed by
a 498-base 39-untranslated region with a consensus sequence
for polyadenylation (AATAAA) at positions 1352–1357 and a
TTTTGT sequence at positions 1322–1327 characteristic of
early response genes (19). The amino acid sequence predicts a
protein of 223 amino acids with a calculated molecular mass of
26 kDa and an isoelectric point of 6.39.
In the data base we found a 507-bp D. melanogaster 5 prime
EST sequence (AA441282) from the Berkeley Drosophila Pro-
ject, which showed homology to the N-terminal 170 amino acid
residues of the human sequence. 39-RACE was used to obtain
the C-terminal part of the sequence for the Drosophila homo-
log. The 59 sequence was confirmed by 59-RACE. The Drosoph-
ila protein sequence has 227 amino acid residues and is shown
in Fig. 3.
GenBankTM Homology Searches and Protein Sequence Anal-
ysis Identify the Protein as the GAS41 Gene Product—Homol-
ogy searches of the cDNA were performed using BLAST algo-
rithms. A BLASTN search revealed strong homologies to open
reading frames in C. elegans (Z77667), S. cerevisiae (Z71383
and Z69382), and Schizosaccharomyces pombe (Z69795.1). EST
sequences for Mus musculus (AA529582 and AA086873) and
partial EST sequences for Rattus norvegicus (AI031024 and
AI012982) were also found. So were sequences for Arabidopsis
thaliana (H76547) and Aspergillus nidulans (AA787444). An
alignment of all nine sequences is shown in Fig. 3. The human
and Drosophila protein sequences show 61% identity and 70%
similarity, whereas the human and the C. elegans sequences
show 48% identity and 59% similarity. The GenBankTM search
also showed that the cloned human sequence was identical to
GAS41, a gene shown by Fischer et al. (14) to be amplified in
some human gliomas.
The N-terminal part of GAS41 seems to be highly conserved
between different species (Fig. 3) with the region corresponding
to residues 80 and 94 of the human sequence being especially
well conserved. Secondary structure prediction rules (20) show
that the C-terminal 60 amino acids are essentially a-helical
(Fig. 2B). This region shows a heptad repeat pattern charac-
teristic for the formation of hydrophobic interactions and the
formation of homo- or heterodimers. The frequency of the acidic
amino acid glutamate and of the basic amino acid lysine is
about twice the frequency in an average protein. An enrich-
ment of acidic amino acids (27%) is found within the C-terminal
60 amino acids. There are no clearly identifiable nuclear local-
ization sequence motifs in the sequence, but we note a basic
highly conserved motif KK or RK at position 60 followed by
another highly conserved basic motif FKLH at position 64.
Together these motifs represent a potential nuclear localization
signal. A number of protein kinase recognition sequence motifs
are also present as follows: for example a potential phospho-
rylation site, 183KKKT186 and/or 184KKTS187 for cAMP-depend-
ent protein kinase (consensus (R/K)XX(S/T) (21)) at the begin-
ning of the a-helical region, a casein kinase II phosphorylation
site 186TSFE189 (consensus (S/T)XX(D/E) (22)) in the same re-
gion, and a tyrosine kinase phosphorylation site 51RNEEM-
SAY58 (consensus (R/K)XX(D/E)XXXY (23)) in the N-terminal
region.
The GAS41 sequence (223 residues) can also be aligned with
the N-terminal portions of the AF-9 (568 residues) and ENL
proteins (559 residues) (Fig. 4 (14)). GAS41 and ENL show 24%
identity and 35% similarity, whereas GAS41 and AF-9 show
21% identity and 30% similarity. Between residues 32 and 89
FIG. 3. Alignment of the amino acid sequences of GAS41 from
9 different species, showing that the protein is conserved from
yeast to man. The human sequence and the D. melanogaster DNA
sequences are from this study. Open reading frames or ESTs from other
species were found in the data bases. For R. norvegicus, A. thaliana,
and A. nidulans only partial sequences are available. Missing parts of
the sequence are indicated by dashes. Gaps introduced to optimize the
alignments are indicated by dots. Bold type is used to identify residues
that are identical in at least 7 of the 9 sequences or where all, or all
except one or two of the known sequences, show identical residues. The
amino acid numbers for the human sequence are shown at the top.
FIG. 4. Alignment of human AF-9, ENL, and GAS41. Identical
amino acid residues are shown in black boxes and similar residues in
gray boxes. Note that GAS41 corresponds only to the first 208 or 206
residues of the longer proteins AF-9 and ENL (568 or 559 residues total
length).
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GAS41 shows 39% identity and 59% similarity to the human
AF-9 protein and 37% identity and 61% similarity to the hu-
man ENL protein (Fig. 4). AF-9 and ENL share 56% identity
and 68% similarity, with the highest homology located to 140
residues at the N terminus and 67 residues at the C terminus.
AF-9 and ENL are thought to belong to a new class of tran-
scription factors (24).
GAS41 Is Present in a Variety of Human Tissues and in Cell
Lines—The distribution of transcripts of GAS41 in a variety of
human tissues was examined by Northern blot hybridization
analysis using as a probe the 1055-bp fragment starting in the
59-translated region at base number 210 and ending in the
39-untranslated region at base 1264. We detected a single
;1.7-kb mRNA transcript corresponding to GAS41 in all eight
tissues tested (Fig. 5A). When normalized using the b-actin
probe as control, equivalent amounts of GAS41 seemed to be
present in the eight tissues listed in Fig. 5.
To see if GAS41 is expressed in human cell lines, immuno-
blots were performed using an affinity-purified rabbit antibody
to GAS41. The antibody was raised against the C-terminal
peptide 206CLKNEIRKLEEDDQAKD222 and affinity-purified
on the peptide coupled to bovine serum albumin. An immuno-
reactive band with an apparent molecular mass of ;26 kDa
was detected in Western blots of whole cell extracts of HeLa
and glioma cells (Fig. 6). In HeLa cells transiently transfected
with the GFP-GAS41 construct the affinity purified antibody
detected the endogenous GAS41 and an additional band
around 52 kDa which probably corresponds to the GFP-GAS41
fusion protein. When the same cell extract was tested with a
GFP antibody, the 52-kDa protein was also found. However in
addition a second slightly larger polypeptide that might corre-
spond to a phosphorylated form of the fusion protein was also
detected by immunoblotting (Fig. 6).
The subcellular localization of GAS41 was determined by
immunofluorescence microscopy using the rabbit GAS41 anti-
body. In interphase cells GAS41 was found in dots throughout
the nucleoplasm with the exception of the nucleolus (Fig. 7A).
In metaphase GAS41 was found distributed uniformly
throughout the mitotic cell but did not specifically bind to the
chromosomes (Fig. 7B).
The nuclear localization of GAS41 was confirmed by moni-
toring HeLa cells transfected with the GFP-GAS41 construct
(Fig. 7C). Again, the GFP fusion protein was distributed in a
punctate form in the nucleoplasm of interphase cells, and the
nucleoli were not stained.
Interaction between GAS41 and NuMA: Immunoprecipita-
tion Experiments, Dot Overlay Assays, and Surface Plasmon
Resonance Experiments—To determine whether GAS41 and
NuMA interact in vivo, coimmunoprecipitation using nuclear
extracts from HeLa cells was performed. NuMA was precipi-
tated using a polyclonal antibody directed against the head
region. Subsequent detection with anti-GAS41 polyclonal anti-
body and an Fc-specific second antibody showed a band in the
expected range of 26 kDa, which was not detected in the control
without first antibody (data not shown). This suggests that
GAS41 and NuMA are contained in the same protein complex
in vivo. The relatively low efficiency of coimmunoprecipitation
suggests that only a fraction of these molecules associate to-
gether in vivo.
An interaction between GAS41 and NuMA was verified in
vitro using dot overlay assays (Fig. 8). GAS41 was expressed as
a GST fusion protein in E. coli. The NuMA N-terminal con-
struct (l1a, residues 1–851) and the construct including the
C-terminal part of the rod (l2b, residues 670–1,700) were
soluble when expressed in E. coli and purified to homogeneity
as described earlier (5). These constructs were spotted onto
nitrocellulose and incubated with either the purified GST-
GAS41 fusion protein or with GST. Binding was monitored by
treating the dot blots with the GST-specific antibody. The re-
sults show that the GST-GAS41 fusion protein bound to the
l2b construct but not to the l1a construct (Fig. 8A). SDS gel
electrophoresis of the protein preparations used in the dot blot
FIG. 5. Human multiple tissue Northern blot containing 2 mg
per lane of poly(A)1 RNA probed sequentially with [32P]dCTP-
labeled GAS41 probe and a control b-actin cDNA probe pro-
vided by the manufacturer. A, Northern blot analysis of transcripts
encoding GAS41 from eight different human tissues shows a single
band. Size (in kb) of the molecular markers are indicated at the left. B,
Northern blot using a b-actin cDNA control. In both heart and skeletal
muscle there are two isoforms of b-actin RNA, a 2- and a 1.6–1.8-kb
form due to hybridization to either the a or g form of actin.
FIG. 6. Polyclonal antibody directed against a C-terminal pep-
tide of GAS41 detects a band of 26 kDa (arrow) in HeLa and
glioma cell lines and a band of ;52 kDa in HeLa cells trans-
fected with the GFP-GAS41 fusion protein.
FIG. 7. A and B, immunofluorescence microscopy of GAS41 with the
rabbit peptide antibody on the glioma cell line U333CG/343MG. A, in
interphase GAS41 is found in a punctate distribution throughout the
nucleoplasm except for the nucleolus. B, in metaphase GAS41 is found
distributed throughout the mitotic cell. C, full-length GAS41 cDNA was
cloned into a GFP vector. HeLa cells transfected with this GFP con-
struct showed a punctate pattern in the nuclei of interphase cells. Bars,
5 mm.
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assays show that there were no contaminating proteins present
that might have mediated this interaction (Fig. 8B). Since GST
alone did not bind to the l2b construct, our results imply a
direct binding of GAS41 to the C-terminal part of the coiled-coil
rod domain of NuMA.
Finally, we analyzed the kinetic properties of the complex
formation between NuMA and GAS41 by surface plasmon res-
onance measurements. The two different NuMA constructs l1a
and l2b (see Fig. 1A) were immobilized on the sensor chip
surface. Binding and dissociation of either GST-GAS41 fusion
protein or GST were monitored in terms of relative units (Fig.
9). When the purified GST-GAS41 fusion protein was used,
binding and dissociation was easily monitored in the range of
50–1000 nM GST-GAS41. The corresponding curves obtained
with the same concentrations of GST were subtracted. The data
shown in Fig. 9 were used to calculate dissociation kinetics,
yielding a koff of 7 3 10
23 s21. The kon value was in the range
of 5 3 104 M21 s21, with the exact value depending on the
fitting method used. Thus, the dissociation constant of the
complex is Kd 5 2 3 10
27 M. In the case of l1a, binding was
barely detectable and a factor of 3500 less compared with l2b
(Fig. 9).
DISCUSSION
A two-hybrid screen using the NuMA C-terminal half as bait
in the yeast two-hybrid system led to a human cDNA which by
sequence was shown to correspond to GAS41. GAS41 specifi-
cally interacts with the C-terminal part of the central coiled-
coil region of NuMA (residues 1048–1700). The C-terminal 50
residues of GAS41 were necessary for NuMA binding in the
two-hybrid system. Dot overlays provided independent proof
that the C-terminal part of the coiled-coil rod region of NuMA
binds to GAS41 since construct l2b, covering residues 670–
1700, showed a strong reaction, whereas the N-terminal con-
struct l1a covering residues 1–851 did not. Independent evi-
dence for the interaction between NuMA and GAS41, as well as
the kinetic constants for association and dissociation of the
NuMA-GAS41 complex were provided by surface plasmon res-
onance studies (Fig. 9). The NuMA fragment l2b bound 3500
times more strongly to GAS41 than did l1a. The calculated
dissociation constant of the NuMA-GAS41 complex is 2 3 1027
M, and this is in the range commonly found for the interaction
of cytoskeletal components (25).
GAS41 is highly conserved among species as diverse as
fungi, yeast, plants, and man (Fig. 3). Thus GAS41 is a general
eukaryotic nuclear protein. This provides a handle to examine
directly the function of GAS41, for instance by making knock-
outs in mice or C. elegans.
Northern blot analysis showed that the mRNA for GAS41
was expressed in all eight human tissues that were tested.
Immunohistochemistry with GAS41-specific antibodies showed
a nuclear-specific localization in interphase cells. Interphase
nuclei were stained in a punctate fashion (Fig. 7A). An inde-
pendent determination of the cellular localization of GAS41
used cells transfected with a GFP-GAS41 construct. In inter-
phase cells again a punctate nuclear distribution of GAS41 was
seen both in fixed cells assayed by immunofluorescence micros-
copy and in living cells analyzed for the distribution of the GFP
construct (Fig. 7C). Further experiments using methods with
higher resolution (for example 4Pi microscopy) are needed to
see if GAS41 colocalizes to a subfraction of NuMA dots reported
for instance with the NuMA 705 antibody (8). In mitotic cells
GAS41 and NuMA have different localizations. GAS41 is found
throughout the cell (Fig. 7B), and NuMA is associated with
spindle poles (1, 4).
The sequence homology of GAS41 with the human AF-9 and
ENL proteins is intriguing (Fig. 4 and Ref. 14). AF-9 is found
fused to the ALL-1 gene in leukemias with t(9:11) transloca-
FIG. 8. Interaction of NuMA with GAS41 in dot overlays. A, the
purified NuMA l1a and NuMA l2b fragments were dotted on to nitro-
cellulose and are indicated at the left. The GST-GAS41 and GST pro-
teins were added as probes and are indicated at the top. The GST
antibody was employed to monitor protein interactions. Note the strong
interaction of GST-GAS41 and l2b, and the lack of interaction of GST-
GAS41 and l1a. B, Coomassie-stained gel to show the purity of the
NuMA constructs l1a and l2b and of the GST-GAS41 and GST
constructs.
FIG. 9. Surface plasmon resonance measurement of the NuMA-
GAS41 interaction. Purified NuMA constructs l2b and l1a were
immobilized on the sensor chip and probed with GST-GAS41 (50–1000
nM). GST was used at equal concentrations to monitor unspecific back-
ground. Graph represents results were concentrations of 250 nM were
used. Values for kon, koff, and Kd in terms of resonance units were
calculated for values from 50, 250, and 1000 nM and are presented in
the table below. The data shows that the ratio of l2b:l1a binding to GST
GAS41 is ;3500:1.
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tions, and ENL is found fused to the ALL-1 gene in leukemias
with t(11:19) translocations. The fact that AF-9 and ENL have
extensive sequence homology as well as several shared se-
quence motifs (e.g. a nuclear targeting sequence, serine-rich
domains and stretches rich in proline or in basic amino acids)
has led to the suggestion that the functional activities of the
proteins coded for by AF-9 and ENL are related and are im-
portant in leukemia (24). Many genes associated with translo-
cations in acute leukemia code for transcription factors (26)
leaving open the question whether AF-9 and ENL might also
code for such proteins (cf. Ref. 24). An artificially constructed
gene which fused the AF-9 gene to the mouse MII (ALL-1) gene
by homologous recombination has been shown to cause acute
leukemia in chimeric mice (27). GAS41 is shorter than AF-9
and ENL, and in contrast to these two proteins lacks a typical
DNA-binding domain for transcriptional activation (Fig. 4).
However, GAS41 could activate transcription together with a
second protein that contains a DNA-binding domain.
We speculate that the interaction between NuMA and
GAS41 shown here may provide a direct link between nuclear
architecture and gene expression. We have shown elsewhere
that NuMA has the ability to polymerize into lattice-like struc-
tures in vivo (8), and we have also shown that NuMA can
self-assemble in vitro into multiarm oligomers, which may be
the structural unit for a nuclear scaffold (9). Obviously, to
prove such a link further evidence has to be provided to show
that GAS41 is involved in transcription and to define the na-
ture and stoichiometry of the GAS41-NuMA complex.
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